UNSPSC 51171514: Bismuth subnitrate

This classification denotes an anti-ulcer agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H19J064BA5. European Medicines Agency schedules Bismuth subnitrate, heavy in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11748MIG. Bismuth subnitrate generally arises in the molecular formula 5BI.4NO3.O.9HO. The term 'bismuth subnitrate' is a European Pharmacopoeia designation. As of Q4 2014, BISMUTH SUBNITRATE remains the US FDA Preferred Term for this commodity.

Bismuth subnitrate bears US NLM identifiers UMLS ID C0053791 and NCI Concept Code C76481. SMILES: [NH+](O)([O-])O[Bi](O[N+](=O)[O-])O[N+](=O)[O-].

UNSPSC 51171514 Bismuth subnitrate is a Commodity code that shows minimal alignment with recent state and local procurement activity. The three opportunities in the recent record—offender drug testing services, a therapeutic pharmacy initiative RFI, and generic pharmaceutical supply through cooperative purchasing—bear no connection to bismuth subnitrate procurement. Bismuth subnitrate is a chemical compound used in pharmaceuticals, cosmetics, and industrial applications, but state and local governments do not appear to be soliciting it directly under this code at present.

The code shows no recent activity matching its nominal scope. The record contains no RFPs, RFQs, ITBs, or IFBs for bismuth subnitrate from state departments, counties, cities, school districts, transit authorities, or special-purpose districts. Without evidence of actual demand, geographic concentration, or repeat buyers in the recent opportunities block, the code presents no actionable procurement signal for business development purposes at this time.